etidronate has been researched along with Rheumatism in 3 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| "4), while the risk factor for OFH was a recent maximum GC dosage (>1." | 1.35 | Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases. ( Amano, K; Kameda, H; Nagasawa, H; Ogawa, H; Sekiguchi, N; Suzuki, K; Takei, H; Takeuchi, T, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kameda, H | 1 |
| Amano, K | 1 |
| Nagasawa, H | 1 |
| Ogawa, H | 1 |
| Sekiguchi, N | 1 |
| Takei, H | 1 |
| Suzuki, K | 1 |
| Takeuchi, T | 1 |
| Curtis, JR | 1 |
| Saag, KG | 1 |
| Sebaldt, RJ | 1 |
| Adachi, JD | 1 |
| Bensen, WG | 1 |
| Bianchi, F | 1 |
| Cividano, A | 1 |
| Craig, GL | 1 |
| Cranney, A | 1 |
| Kaminska, E | 1 |
| Gordon, M | 1 |
| Steele, M | 1 |
| Goldsmith, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Vertebral Fracture and Osteonecrosis of the Femoral Head Associated With High-dose Glucocorticoid Therapy[NCT00679978] | 60 participants (Actual) | Observational | 2001-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for etidronate and Rheumatism
| Article | Year |
|---|---|
Intermittent cyclic therapy with etidronate prevents corticosteroid-induced bone loss: two years of follow-up.
Topics: Adrenal Cortex Hormones; Bone Density; Cohort Studies; Drug Administration Schedule; Etidronic Acid; | 1996 |
2 other studies available for etidronate and Rheumatism
| Article | Year |
|---|---|
Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases.
Topics: Bone Density; Bone Density Conservation Agents; Etidronic Acid; Female; Femur Head Necrosis; Glucoco | 2009 |
Prevention and treatment of glucocorticoid-induced osteoporosis.
Topics: Alendronate; Bone Density Conservation Agents; Calcium; Cost-Benefit Analysis; Diphosphonates; Etidr | 2007 |